ValueBuddies.com : Value Investing Forum - Singapore, Hong Kong, U.S.

Pages (795): « Previous 1 … 470 471 472 473 474 … 795 Next »

Date & Time	Title
Wed, 11 Dec 2024 09:00:00 +0800	Partnership Established to Advance WHO's Road Map for Neglected Tropical Diseases 2021-2030
Wed, 11 Dec 2024 08:00:00 +0800	SK chemicals and Hyundai Collaborate on Sustainable Automotive Development
Wed, 11 Dec 2024 07:36:00 +0800	Viking Engineering Laboratory Achieves ISO 17025 Accreditation
Wed, 11 Dec 2024 07:00:00 +0800	Fiji Airways launches first-ever nonstop flight between Dallas Fort Worth and the tropical paradise of Fiji
Wed, 11 Dec 2024 03:00:00 +0800	J.F. Lehman & Company Raises $2.2 Billion for Oversubscribed Fund VI
Wed, 11 Dec 2024 02:10:00 +0800	Evolving Global Asset Management Industry in Focus at Asset Abu Dhabi
Wed, 11 Dec 2024 01:54:00 +0800	A Glimpse into the Brilliant Strategy Behind Huawei's Leading Foldable Smartphone Innovation
Wed, 11 Dec 2024 01:44:00 +0800	China Matters' Feature: Musicians on How History Enlightens the Future
Wed, 11 Dec 2024 00:30:00 +0800	Atomicwork releases its State of AI in IT Report for 2025: North American IT Leaders see high ROI with AI adoption
Wed, 11 Dec 2024 00:00:00 +0800	CASETiFY Expands Into Travel With Luggage Collection
Wed, 11 Dec 2024 00:00:00 +0800	Momentus Technologies Launches AI-Powered WeTrack Risk Functionality to Empower Venues and Events Worldwide
Tue, 10 Dec 2024 23:42:00 +0800	IBM Brings the Speed of Light to the Generative AI Era with Optics Breakthrough
Tue, 10 Dec 2024 23:30:00 +0800	Joget White Label Offering Empowers Digital Solutions Companies to Launch Their Own Branded Platforms
Tue, 10 Dec 2024 23:17:00 +0800	State Grid Xuzhou Power Supply Company conducts comprehensive inspection of unmanned aerial vehicle substations
Tue, 10 Dec 2024 23:00:00 +0800	【2024 ASH】TransThera Announces the Phase I Study Results of TT-01488, a Novel Non-Covalent BTK Inhibitor, in Patients with Relapsed or Refractory B-cell Malignancies
Tue, 10 Dec 2024 22:31:00 +0800	Live from ASH 2024 \| Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Months
Tue, 10 Dec 2024 22:20:00 +0800	Live from ASH 2024 \| Ascentage Pharma Releases Updated Data of Bcl-2 Inhibitor Lisaftoclax in MDS that Demonstrates Potential Clinical Benefits and Favorable Safety
Tue, 10 Dec 2024 22:06:00 +0800	Young visitors savor Jiangsu's floral beauty mingled with economic prowess
Tue, 10 Dec 2024 22:03:00 +0800	Capture, Celebrate, and Save Big: Reolink's Holiday Deals and #reocap Fun!
Tue, 10 Dec 2024 22:00:00 +0800	DL E&C Marks First Entry into Canadian Blue Ammonia Market

Pages (795): « Previous 1 … 470 471 472 473 474 … 795 Next »

Login
Username:
Password:	Lost Password?
	Remember me